Tumor‐infiltrating macrophages constitute a highly heterogeneous group within the TME.[43] Collectively, macrophages within the YM101 group exhibited enrichment in immune‐supportive pathways, including inflammatory response, various cytokine or chemokine pathways, antigen presentation and processing, TLR, NOD‐like receptor (NLR), RIG‐I‐like receptor (RLR), and cytosolic DNA sensing pathways (Figure S5a, Supporting Information). The gene discussed is DHX58; the disease is neoplasm.